Pulmonary/Concepts
Methodology for a rapid protocol to rule out pulmonary embolism in the emergency department*,**,

https://doi.org/10.1067/mem.2003.268Get rights and content

Abstract

We propose an emergency department (ED) pulmonary embolism rule-out protocol based on pretest probability assessment coupled with either a negative D -dimer assay result or a negative D -dimer assay result plus a normal alveolar dead-space measurement. We examine the safety, efficiency, and feasibility of such a protocol, paying special attention to implicit and explicit strategies of pretest probability assessment among patients with suspected pulmonary embolism. Finally, we assess the potential effect of the proposed pulmonary embolism rule-out protocol on use of imaging resources and ED throughput. [Ann Emerg Med. 2003;42:266-275.]

Introduction

Emergency physicians are frequently faced with the challenge of excluding or diagnosing pulmonary embolism. Studies at academic emergency departments (EDs) in Charlotte, NC, Detroit and Royal Oak, MI, Phoenix, AZ, Toledo, OH, and St. Louis, MO,1, 2, 3 have shown that emergency physicians order a pulmonary vascular imaging study (either a scintillation ventilation-perfusion lung scan or a contrast-enhanced computed tomographic [CT] angiogram of the chest) on approximately 0.6% to 2.0% of all patients visiting the ED at these hospitals. If these data are generalized to the US population, between 500,000 and 2 million ED patients undergo a pulmonary vascular imaging study annually. The cost (in US dollars) to the hospital to perform a ventilation-perfusion or CT scan is $100 to $200 in Canada and $200 to $500 in the United States, and the charge to the patient is more than $1,000 for either test in the United States.4, 5, 6 Both tests expose the patient to ionizing radiation. A further limitation is that these tests might be available only at certain times and can require several hours to complete.

Accordingly, multiple investigators interested in pulmonary embolism have focused on the utility of sensitive, inexpensive, less invasive, and more rapid methods to rule out pulmonary embolism. This report examines the published data evaluating D -dimer measurement in conjunction with other criteria to exclude the diagnosis of pulmonary embolism. We suggest the adoption of 3 guiding principles for the pulmonary embolism rule-out strategy: safety, efficiency, and feasibility.

Section snippets

Safety of the proposed protocol

The safety of a pulmonary embolism rule-out protocol is primarily determined by the probability of false-negative results. This can be expressed as the posttest probability of pulmonary embolism after the pulmonary embolism rule-out protocol returns a negative result. Because it is unlikely that any protocol will yield a 0% posttest probability of pulmonary embolism, we suggest a maximum acceptable upper limit of 1.0% on the basis of 2 lines of evidence. First, reports of the rate of subsequent

D -Dimer assays

The efficiency of a pulmonary embolism rule-out protocol can be defined by its effect on resource use. The process of pretest probability assessment has no measurable cost, and therefore, the bulk of the direct cost of the pulmonary embolism rule-out protocol can be calculated from the cost of the objective tests, the D -dimer assay (plus or minus the dead-space measurement), incurred as a result of the protocol plus the cost of additional imaging. In the United States, the bedside qualitative D

Feasibility of the protocol

At many centers, methods to augment the administrative feasibility must be considered before implementation of a pulmonary embolism rule-out protocol. At some hospitals, the pulmonary embolism rule-out protocol might improve the efficiency of evaluation for pulmonary embolism, which can be used to help justify its use. If the protocol is to be implemented with a point-of-care test, we believe that the hospital should use the whole-blood agglutination assay (SimpliRED) or a newer-generation

References (48)

  • KL Dunn et al.

    Normal D -dimer levels in emergency department patients suspected of acute pulmonary embolism

    J Am Coll Cardiol

    (2002)
  • MA Rodger et al.

    Steady-state end-tidal alveolar dead space fraction and D -dimer: bedside tests to exclude pulmonary embolism

    Chest

    (2001)
  • R Prediletto et al.

    Natural course of treated pulmonary embolism

    Chest

    (1990)
  • S Farrell et al.

    A negative simpliRED D -dimer assay result does not exclude the diagnosis of deep vein thrombosis or pulmonary embolus in emergency department patients

    Ann Emerg Med

    (2000)
  • MF Knecht et al.

    Clinical evaluation of an immunoturbidimetric D -dimer assay in the diagnostic procedure of deep vein thrombosis and pulmonary embolism

    Thromb Res

    (1997)
  • M Veitl et al.

    Comparison of four rapid D -dimer tests for diagnosis of pulmonary embolism

    Thromb Res

    (1996)
  • M Duet et al.

    A new quantitative D -dimer assay appropriate in emergency: reliability of the assay for pulmonary embolism exclusion diagnosis

    Thomb Res

    (1998)
  • JA Kline et al.

    Diagnostic accuracy of a bedside D -dimer assay and alveolar dead-space measurement for rapid exclusion of pulmonary embolism: a multicenter study

    JAMA

    (2001)
  • S Saini et al.

    Technical cost of CT examinations

    Radiology

    (2001)
  • RD Hull et al.

    Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan

    Ann Intern Med

    (1983)
  • RA Novelline et al.

    The clinical course of patients with suspected pulmonary embolism and a negative pulmonary arteriogram

    Radiology

    (1978)
  • MV Gosselin et al.

    Unsuspected pulmonary embolism: prospective detection on routine helical CT scans

    Radiology

    (1998)
  • WS Richardson

    Where do pretest probabilities come from?

    ACP J Club

    (1999)
  • RE Jackson et al.

    Emergency physician assessment of the pretest probability of pulmonary embolism

    Acad Emerg Med

    (1999)
  • Cited by (0)

    *

    Dr. Wells is the recipient of a Canada Research Chair Award.

    **

    Neither of the authors has any financial relationship to any of the products mentioned in this article.

    Reprints not available from the authors.

    View full text